Amyndas Announces Positive Top-Line Phase 2 Results for Investigational AMY-101 in Adults With Periodontal Inflammation and Gingivitis
Jotup,
Am Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel complement…